Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Frequency of atypical vascularization during IAC for retinoblastoma

Jacob Pe'er; Nadav Levinger; Jose Cohen; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1643. doi:

ARVO Annual Meeting Abstract July 2018

Serum exosome analysis as a predictive biomarker for metastatic uveal melanoma

Shahar Frenkel; Shahar Luski; Pratibha Gaur; Jacob Pe'er; Saray Tabak; Elie Beit-Yannai

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3186. doi:

ARVO Annual Meeting Abstract June 2017

Leaky Choroidal Nevi: A Clinical, Imaging and Therapeutic Analysis

Shahar Frenkel; Gustavo A. Gutiérrez-Vargas; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1787. doi:

ARVO Annual Meeting Abstract June 2017

The Use of Intravitreal Methotrexate for Treating Vitreoretinal Lymphoma

Jacob Pe'er; Ron Kaufman; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1800. doi:

ARVO Annual Meeting Abstract September 2016

The clinical presentation of retinoblastoma patients with mosaics

Shahar Frenkel; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3672. doi:

ARVO Annual Meeting Abstract September 2016

Brachytherapy with Ru-106 plaques as a primary treatment for retinoblastoma in Israel

Jacob Pe'er; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3679. doi:

ARVO Annual Meeting Abstract June 2015

Novel combinatorial treatment option for metastatic uveal melanoma

Shahar Frenkel; Dudi Shneor; Alik Honigman; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4337. doi:

ARVO Annual Meeting Abstract April 2014

NFkB Inhibition in Uveal Melanoma - construction of a new delivery system

Shahar Frenkel; Dudi Shneor; Alik Honigman; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):846. doi:

ARVO Annual Meeting Abstract April 2014

sIL-2R an immuno-biomarker for prediction of metastases in uveal melanoma

Vivian Barak; Jacob Pe'er; Inna Kalickman; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5076. doi:

ARVO Annual Meeting Abstract June 2013

Genetic Characterization among 232 Retinoblastoma Patients

Jacob Pe'er; Ofira Zloto; Michael Weintraub; Michal Sagi; Israela Lerer; Avishag Nadel; Ido Rot; Naomi Shoshani; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3976. doi:

ARVO Annual Meeting Abstract June 2013

Targeting Uveal Melanoma Response to Hypoxia

Dudi Shneor; Alik Honigman; Jacob Pe'er; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4527. doi:

ARVO Annual Meeting Abstract June 2013

NFkB Inhibition in Uveal Melanoma - Contrariety of in vitro vs. in vivo Results

Shahar Frenkel; Dudi Shneor; Jacob Pe'er; Alik Honigman

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4529. doi:

Anatomy and Pathology/Oncology January 2013

Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma

PDF

Ofira Zloto; Jacob Pe'er; Shahar Frenkel
TAGS: patient referral, melanoma, neoplasm metastasis, mortality, neoplasms, intraocular melanoma, gender differences, tumor size
Invest. Ophthalmol. Vis. Sci.. 2013; 54(1):652-656. doi: 10.1167/iovs.12-10365

Anatomy and Pathology/Oncology January 2013

Insulin-Like Growth Factor-1 as a Predictive Biomarker for Metastatic Uveal Melanoma in Humans

PDF

Shahar Frenkel; Ofira Zloto; Jacob Pe'er; Vivian Barak
TAGS: biological markers, insulin-like growth factor i, neoplasm metastasis, intraocular melanoma
Invest. Ophthalmol. Vis. Sci.. 2013; 54(1):490-493. doi: 10.1167/iovs.12-10228

Anatomy and Pathology/Oncology October 2012

The Role of RASSF1A in Uveal Melanoma

PDF

Olga Dratviman-Storobinsky; Yoram Cohen; Shahar Frenkel; Efrat Merhavi-Shoham; Shimrit Dadon-Bar El; Natalia Binkovsky; Jacob Pe'er; Nitza Goldenberg-Cohen
TAGS: polymerase chain reaction, cisplatin, cell lines, cell transplantation, methylation, mice, neoplasms, intraocular melanoma
Invest. Ophthalmol. Vis. Sci.. 2012; 53(6):2611-2619. doi: 10.1167/iovs.11-7730

ARVO Annual Meeting Abstract March 2012

Adhesion Properties Of Human Uveal Melanoma

AINAT KLEIN, V; SHIRI KLEIN; AMNON PELED; SHAHAR FRENKEL

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3390. doi:

ARVO Annual Meeting Abstract March 2012

A New in vivo Model for Testing Treatments for Liver Metastases of Uveal Melanoma: Model Construction and Use for Testing NFkB Inhibition

Shahar Frenkel; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3422. doi:

ARVO Annual Meeting Abstract March 2012

FAM161A Produces Two Protein Isoforms with a Differential Retinal Expression Pattern

Dror Sharon; Alexey Obolensky; Elia Shevach; Eyal Banin; Shahar Frenkel; Adi Inbal; Dikla Bandah-Rozenfeld

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1618. doi:

Anatomy and Pathology/Oncology December 2011

Carcinoembryonic Antigen Cell Adhesion Molecule-1 (CEACAM1) in Posterior Uveal Melanoma: Correlation with Clinical and Histological Survival Markers

PDF

Nur Khatib; Jacob Pe'er; Rona Ortenberg; Jacob Schachter; Shahar Frenkel; Gal Markel; Radgonde Amer
TAGS: extracellular matrix, cell adhesion, carcinoembryonic antigen, neoplasms, intraocular melanoma, molecule
Invest. Ophthalmol. Vis. Sci.. 2011; 52(13):9368-9372. doi: 10.1167/iovs.10-6006

ARVO Annual Meeting Abstract April 2011

Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma

Ofira Zloto; Jacob Pe'er; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3265. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Frequency of atypical vascularization during IAC for retinoblastoma

Serum exosome analysis as a predictive biomarker for metastatic uveal melanoma

Leaky Choroidal Nevi: A Clinical, Imaging and Therapeutic Analysis

The Use of Intravitreal Methotrexate for Treating Vitreoretinal Lymphoma

The clinical presentation of retinoblastoma patients with mosaics

Brachytherapy with Ru-106 plaques as a primary treatment for retinoblastoma in Israel

Novel combinatorial treatment option for metastatic uveal melanoma

NFkB Inhibition in Uveal Melanoma - construction of a new delivery system

sIL-2R an immuno-biomarker for prediction of metastases in uveal melanoma

Genetic Characterization among 232 Retinoblastoma Patients

Targeting Uveal Melanoma Response to Hypoxia

NFkB Inhibition in Uveal Melanoma - Contrariety of in vitro vs. in vivo Results

Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma

Insulin-Like Growth Factor-1 as a Predictive Biomarker for Metastatic Uveal Melanoma in Humans

The Role of RASSF1A in Uveal Melanoma

Adhesion Properties Of Human Uveal Melanoma

A New in vivo Model for Testing Treatments for Liver Metastases of Uveal Melanoma: Model Construction and Use for Testing NFkB Inhibition

FAM161A Produces Two Protein Isoforms with a Differential Retinal Expression Pattern

Carcinoembryonic Antigen Cell Adhesion Molecule-1 (CEACAM1) in Posterior Uveal Melanoma: Correlation with Clinical and Histological Survival Markers

Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma

To View More...

You must be signed into an individual account to use this feature.